Increasing access to essential cancer medicines To be truly effective in addressing the problem of access, a new partnership approach is needed. Simply making cancer medicines available does not guarantee that patients will receive the right medicines at the right time. Increasing access to cancer medicines in LLMICs is challenging. Many LLMICs do not have sufficient resources to respond to the needs of people living with cancer and have a limited availability of essential medicines, diagnostics and complementary treatments required for good cancer treatment and care. If left unchecked, deaths from cancer in LLMICs are expected to rise to 4 million by 2040. ![]() ![]() In 2020, more than 3.5 million new cancer cases were diagnosed in low-and lower middle-income countries (LLMICs) 1 and an estimated 2.3 million premature deaths were caused by cancer. Increasing access to essential medicines.
0 Comments
Leave a Reply. |